The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of pharmacogenetic variations in ABCG2 with cisplatin toxicity in patients with head and neck squamous cell carcinoma.
B. Lee
No relevant relationships to disclose
R. Slack
No relevant relationships to disclose
J. J. Hwang
No relevant relationships to disclose
K. Steadman
No relevant relationships to disclose
W. Harter
No relevant relationships to disclose
B. J. Davidson
No relevant relationships to disclose
K. A. Newkirk
No relevant relationships to disclose
P. G. Shields
No relevant relationships to disclose
R. Goldman
No relevant relationships to disclose
J. F. Deeken
No relevant relationships to disclose